This brand name is authorized in Austria, Croatia, Lithuania, Turkey
The drug ALVEOFACT contains one active pharmaceutical ingredient (API):
|
1
Beractant
UNII S866O45PIG - BERACTANT
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R07AA02 | Natural phospholipids | R Respiratory system → R07 Other respiratory system products → R07A Other respiratory system products → R07AA Lung surfactants |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-384673340 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1070285, 1073525 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699702779004 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
